Benign meningiomas (WHO Grade I) with atypical histological features: correlation of histopathological features with clinical outcomes.
暂无分享,去创建一个
A. Niemierko | W. Curry | R. Martuza | A. Stemmer-Rachamimov | H. Shih | J. Loeffler | D. Mcguone | A. Marciscano | F. Barker | M. Larvie | K. Oh | D. McGuone
[1] C. López-Ginés,et al. Genetic changes with prognostic value in histologically benign meningiomas. , 2013, Clinical neuropathology.
[2] J. Barnholtz-Sloan,et al. CBTRUS statistical report: primary brain and central nervous system tumors diagnosed in the United States in 2007-2011. , 2012, Neuro-oncology.
[3] K. Kawai,et al. Significance of Simpson grading system in modern meningioma surgery: integration of the grade with MIB-1 labeling index as a key to predict the recurrence of WHO Grade I meningiomas. , 2012, Journal of neurosurgery.
[4] A. von Deimling,et al. Improved correlation of the neuropathologic classification according to adapted world health organization classification and outcome after radiotherapy in patients with atypical and anaplastic meningiomas. , 2011, International journal of radiation oncology, biology, physics.
[5] J. Villano,et al. Update on meningiomas. , 2011, The oncologist.
[6] M. Berger,et al. The relevance of Simpson Grade I and II resection in modern neurosurgical treatment of World Health Organization Grade I meningiomas. , 2010, Journal of neurosurgery.
[7] Pascal Pommier,et al. Combined proton and photon conformal radiotherapy for intracranial atypical and malignant meningioma. , 2009, International journal of radiation oncology, biology, physics.
[8] G. Barnett,et al. Long-term experience with World Health Organization grade III (malignant) meningiomas at a single institution. , 2009, International journal of radiation oncology, biology, physics.
[9] W. Curry,et al. LONG‐TERM RECURRENCE RATES OF ATYPICAL MENINGIOMAS AFTER GROSS TOTAL RESECTION WITH OR WITHOUT POSTOPERATIVE ADJUVANT RADIATION , 2009, Neurosurgery.
[10] A. Perry,et al. Gray Zones in Brain Tumor Classification: Evolving Concepts , 2008, Advances in anatomic pathology.
[11] B. Guthrie,et al. Hitting a moving target: evolution of a treatment paradigm for atypical meningiomas amid changing diagnostic criteria. , 2008, Neurosurgical focus.
[12] D. Kong,et al. Relationship between malignant subtypes of meningioma and clinical outcome , 2007, Journal of Clinical Neuroscience.
[13] B. Scheithauer,et al. The 2007 WHO Classification of Tumours of the Central Nervous System , 2007, Acta Neuropathologica.
[14] J. Schramm,et al. Interinstitutional variance of postoperative radiotherapy and follow up for meningiomas in Germany: impact of changes of the WHO classification , 2005, Journal of Neurology, Neurosurgery & Psychiatry.
[15] P. Gutin,et al. Diagnosis and Treatment of Atypical and Anaplastic Meningiomas: A Review , 2005, Neurosurgery.
[16] I. Whittle,et al. The accuracy of meningioma grading: a 10‐year retrospective audit , 2005, Neuropathology and applied neurobiology.
[17] M. Maor,et al. Radiotherapy after surgery for benign cerebral meningioma. , 2004, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[18] Chih‐Yi Hsu,et al. Histopathology and MIB‐1 labeling index predicted recurrence of meningiomas , 2002, Cancer.
[19] R. Ojemann,et al. Management of Atypical and Malignant Meningiomas: Role of High-dose, 3D-conformal Radiation Therapy , 2000, Journal of Neuro-Oncology.
[20] J M Buatti,et al. Benign meningiomas: primary treatment selection affects survival. , 1997, International journal of radiation oncology, biology, physics.
[21] L. Palma,et al. Long-term prognosis for atypical and malignant meningiomas: a study of 71 surgical cases. , 1997, Journal of neurosurgery.
[22] M. Fukui,et al. MIB1 staining index and scoring of histologic features in meningioma. Indicators for the prediction of biologic potential and postoperative management , 1994, Cancer.
[23] B J Goldsmith,et al. Postoperative irradiation for subtotally resected meningiomas. A retrospective analysis of 140 patients treated from 1967 to 1990. , 1994, Journal of neurosurgery.
[24] W. Friedman,et al. The meningioma controversy: postoperative radiation therapy. , 1988, International journal of radiation oncology, biology, physics.
[25] J. Jääskeläinen,et al. Atypical and anaplastic meningiomas: radiology, surgery, radiotherapy, and outcome. , 1986, Surgical neurology.
[26] J. Barnholtz-Sloan,et al. CBTRUS statistical report: Primary brain and central nervous system tumors diagnosed in the United States in 2006-2010. , 2013, Neuro-oncology.
[27] Thomas Backer-Grøndahl,et al. The histopathological spectrum of human meningiomas. , 2012, International journal of clinical and experimental pathology.
[28] E. B. Butler,et al. Malignant meningioma: An indication for initial aggressive surgery and adjuvant radiotherapy , 2004, Journal of Neuro-Oncology.
[29] E. Berg,et al. World Health Organization Classification of Tumours , 2002 .
[30] E. Wenkel,et al. Benign meningioma: partially resected, biopsied, and recurrent intracranial tumors treated with combined proton and photon radiotherapy. , 2000, International journal of radiation oncology, biology, physics.
[31] G. Barnett,et al. Local control and overall survival in atypical meningioma: a retrospective study. , 2000, International journal of radiation oncology, biology, physics.
[32] A. Asai,et al. Clinical and histopathological analysis of proliferative potentials of recurrent and non-recurrent meningiomas , 1996, Acta Neuropathologica.